Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$36.73 USD
+1.10 (3.09%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $36.72 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | 15.15% |
ABR | 1.53 |
Earnings ESP
|
-16.02% |
---|---|
Current Year | -1.34 |
Next Year | 0.04 |
EPS (TTM) | -2.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 200.47M | 213.63M | 786.12M | 987.91M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 213.21M | 234.14M | 813.15M | 1.21B |
Low Estimate | 189.45M | 187.35M | 748.84M | 914.26M |
Year ago Sales | 110.40M | 146.38M | 396.59M | 786.12M |
Year over Year Growth Est. | 81.58% | 45.94% | 98.22% | 25.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.21 | -1.34 | 0.04 |
# of Estimates | 11 | 9 | 11 | 11 |
Most Recent Consensus | -0.37 | -0.33 | -1.55 | -0.78 |
High Estimate | -0.22 | 0.10 | -0.97 | 1.35 |
Low Estimate | -0.43 | -0.46 | -1.68 | -0.85 |
Year ago EPS | -1.17 | -0.73 | -4.45 | -1.34 |
Year over Year Growth Est. | 74.36% | 71.23% | 69.89% | 103.39% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 2 | 2 | 2 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 3 | 2 | 3 | 2 |
Down Last 60 Days | 8 | 7 | 9 | 8 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.21 | -1.34 | 0.04 |
7 Days Ago | -0.29 | -0.18 | -1.29 | 0.16 |
30 Days Ago | -0.26 | -0.16 | -1.27 | 0.22 |
60 Days Ago | -0.18 | -0.07 | -1.07 | 0.65 |
90 Days Ago | -0.19 | -0.07 | -1.10 | 0.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.40 | -1.50 | -0.09 |
Zacks Consensus Estimate | -0.30 | -0.21 | -1.34 | 0.04 |
Earnings ESP | -16.02% | -88.10% | -11.72% | -310.64% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.54 | -0.73 | -1.17 | NA |
Estimate | -0.33 | -0.54 | -0.66 | -0.84 | NA |
Difference | 0.05 | 0.00 | -0.07 | -0.33 | -0.09 |
Surprise | 15.15% | 0.00% | -10.61% | -39.29% | -8.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more